Clinical trial

A Three-Month Clinical Study to Assess the Gingivitis Effects of Various Dentifrices

Name
2021080
Description
The objective of this learning clinical study is to assess the gingivitis effects of four different dentifrices over a 3-month period.
Trial arms
Trial start
2021-10-20
Estimated PCD
2022-02-06
Trial end
2022-02-06
Status
Completed
Treatment
0.76% Sodium Monofluorophosphate Dentifrice
Whole mouth brushing with a toothpaste, twice daily for the duration of the study.
Arms:
0.76% Sodium Monofluorophosphate Dentifrice
1.15% Sodium Monofluorophosphate Dentifrice
Whole mouth brushing with a toothpaste, twice daily for the duration of the study.
Arms:
1.15% Sodium Monofluorophosphate Dentifrice
0.454% Stannous Fluoride Dentifrice
Whole mouth brushing with a toothpaste, twice daily for the duration of the study.
Arms:
Marketed 0.454% Stannous Fluoride Dentifrice
0.454% Stannous Fluoride Dentifrice
Whole mouth brushing with a toothpaste, twice daily for the duration of the study.
Arms:
0.454% Stannous Fluoride Dentifrice
Size
115
Primary endpoint
Löe-Silness Gingivitis Evaluation
3 Months
Eligibility criteria
Inclusion Criteria: * Be at least 18 years of age; * Provide written informed consent prior to participation and be given a signed copy of the informed consent form; * Be in general good health as determined by the Investigator based on a review of the health history/update for participation in the trial; * Have at least 16 gradable teeth; * Have mild to moderate gingivitis with a range of 10% to 70% bleeding sites; * Agree to return for scheduled visits and follow the study procedures; * Agree to refrain from use of any non-study oral hygiene products for the duration of the study; * Agree to delay any elective dentistry, including dental prophylaxis, until the completion of the study. Exclusion Criteria: * Having taken antibiotic, anti-inflammatory, or anti-coagulant medications within 4 weeks of the Baseline Visit; * Have any oral conditions that could interfere with study compliance and/or examination procedures, such as widespread caries, soft or hard tissue tumor of the oral cavity, or advanced periodontal disease; * Removable oral appliances; * Fixed facial or lingual orthodontic appliances; * Self-reported pregnancy or lactation; * Any diseases or condition that might interfere with the safe participation in the study; and * Inability to undergo study procedures.
Protocol
{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'TREATMENT', 'maskingInfo': {'masking': 'DOUBLE', 'whoMasked': ['PARTICIPANT', 'INVESTIGATOR']}}, 'enrollmentInfo': {'count': 115, 'type': 'ACTUAL'}}
Updated at
2023-11-20

1 organization

3 products

1 indication

Organization
Procter and Gamble
Indication
Gingivitis